Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics & Toxicology
Novel nanoformulated chemotherapeutics and diagnostics require demonstration of efficacy and safety in appropriate animal models prior to clinical translation of the concept. Pharmacokinetic studies are also important to optimize dosing regimen.
Listed in Datasets | publication by group NCL Protocols
Version 1.0 - published on 18 Oct 2022 doi:10.17917/W63A-GR02 - cite this
Licensed under these terms
Supporting Docs
- Guide to NCL In Vivo Studies.pdf(PDF | 528 KB)
NCL Protocols
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.